Press Release: BioFlyte : BioFlyte Successfully Validates Aerosolized Fentanyl Detection Capabilities
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--BioFlyte adds fentanyl to its classification library for its BioTOF z200 following in-house proof of concept and third party validation testing
Read full article »
BioFlyte is a New Mexico-based bioaerosol surveillance company that develops products such as biothreat detection and identification equipment for the healthcare industry.
Read more